Alphamind Brands
Anahit
Bright Minds
Cilo Cybin
Cybin Technologies
Cybin Therapeutics
EGF Theramed Health Corp.
Ehave
Ei.Ventures
Green Parrot Labs
HAVN Life
Hikma
Mindset Pharma
Minerco, Inc
Thoughtful Brands, Inc.
Neon Mind
New Wave Corp.
Octarine
OmTerra
Optosom
Pharmadelic Labs
Psilocin Corp.
Psilocybin Technology
Psybio Therapeutics
Psyched Wellness Corp.
Psychedelic Insights
Pure Extracts
Rapid Therapeutic Science Laboratories
Red Light Holland Corp.
Roadman
The Emmes Company, LLC
Think Myco
Tripsitters
Verrian
Xenomics
atai Life Sciences
Braxia Scientific
COMPASS Pathways
Cybin
Flourish Mushroom Labs Inc.
Frontier Neurochem
Mydecine Innovations Group Inc.
OLP Therapeutics
Pfizer
Rxoid
Sansero
Silo Wellness
WGG
Yield Growth Corp
The Buena Vida
Luz Eterna Retreats
Magic Mushrooms Dispensary
The Myco Grow
Truffles Therapy
Het Wonder Van Bestaan
Binnenreizen
Shamanic Space
A Whole New High
Inward Bound
Trip Safe
New Moon Psychedelic Retreats
Kiyumi
Therapeutic Sitting Service
Plant Medicine Miracles
Psilohuasca
Essence Institute
Truffle Healing
St. Vincent's Hospital, Melbourne
Earth Resonance
ShroomsDirect
Blue Goba
Psilo Supplements
Champignon Magique
Medicinal Mushroom Dispensary
Eleusian Biosciences
920 Coalition
Microdose Nature
Quality Spores
Midwest Grow Kits
North Spore
Atman Retreat
Cyber-Shrooms
ProviThor
Psilo Retreat
Earthly Microdosing
Osmosis
Soul Treats
Sero
Micro Mushroom Resource Centre
Beckley Psytech
Azarius
CaaMTech
Aion Therapeutic
PCAI
IntelGenx
CannaGlobal Wellness
The Lundquist Institute
TRYP Therapeutics
Rritual
Captiva Verde
Magical Brands
Canadian Psilocybin Collective
M2BIO
Shroomery
PsiloBrain
Mindcure
Smallhold
Empyrean
Four Sigmatic
BioPharm
Aquilino Cancer Center
Pharmadrug
Better Plant Sciences
Pharmather
Cannsun Medhel
Pilz BioScience
Silo Pharma
Primo Nutraceuticals Inc.
Medcan Biotechnologies
Psilocybrand
Allied Corp
Gwella Mushrooms
Kind Stranger
Headland
Mera Life Sciences
The Entheogen Genome Project
Soul Cybin
Leiio Wellness
bluemasi
XPhyto
Eighth Gen Therapeutics
Maylo Therapeutics
Incannex
Monash
NeonMind Biosciences Inc.
AIkido Pharma
Psyence
Alkemist Labs
Namaste Technologies
Conscious Mind
Sunstone Therapies
AMRI
GoodCap
ATMA Journey Centers Inc.
Atitlantis
Optimi Health
Syreon Research Institute
MYND Life Sciences Inc.
Forest Medicine Coaching
Micro-dosing for Healing
California Center for Psychedelic Therapy
Knowde Group Inc.
Lattice Biologics
Halucenex
CURE Pharmaceutical
The Sentinel
Psirenity
PsiloTec
Levitee Labs
Cannabics Pharmaceuticals
Mycrodose Therapeutics
Cubed3 Biotech
Mr. Psychedelic Law
High Rise
Lennham Pharmaceuticals
Entheogenesis Australis
Limina Foundation
Healing Advocacy Fund
Society for Psychedelic Outreach Reform and Education (SPORE)
Usona Institute
Numinus
Core One Labs
MagicMed Industries
Wesana Health
Nova Mentis Life Science Corp.
Lobe Sciences
Eversio Wellness
Filament Health
Ocean Bio
Apex Labs
3Amigos Psilocybin
Albert Labs
MycoMedia Life Sciences
MindLift
Circadian Wellness
Diaspora Psychedelic Society
Zylorion
Within Center
MagicMushroomKit.ca
Psilouette
Triptherapie
Elemental
Awaken Aba
TripzOregon
Mind Trek
Oregon Psychedelic Guide
Oregon Trip Sitters
InnerTrek
NW Psilocybin
Tree of Life
Fabulous Healing
Fractal Soul PDX
Mushroom Illuminations
Altered State of Consciousness Therapy
HeartSong NW
EPIC Healing Eugene
Renew Wonder
Grassroots Wellness
PsycheDoula
Changa Institute
Clinical Cognitive Training
Aya Healing Retreats
Advanced Professional Certifications
Earth Medicine Center
Psilocybin SF
Entheogen Institute
Mending Mindcelium
Myco-Method
The Leela School of Awakening
ACADIA PROFESSIONAL LEARNING
Sanju Goswami
Damian Kettlewell
Lyla Marquez
Ruth Anderson
Alex Polvi
Amanda Gerace
Amy Koehlinger
Arah Gould
Ashley Collin
Erik Blender
Bryan Arnold
Catherine Jonas
Christine Marie Aitchison
Cindy Brodner
David Naftalin
Douglas Wingate
Erin Draper
Erin Pappas
Evelyn Cushing
Heidi Venture
Jadryn Ownbey
Jay Cusker
Jeanette Small
Jim Klopfer
Johnny Dwork
Kat Thompson
Liat Nadler
Matthew Wissler
Melinda Halpern
Michele Burke
Michelle Harrell
Olivia Dye
Patrick Winczewski
Phyllis Moses
Rebecca Ahnsdotter
Ryan Baker
Ryan Dutra
Ryan Swan
Sarah Honeycutt
Scott Holden
Susanne Ulvi
Tracey Tiret
William Thomas
Aaron Donne
Henry Fields
Matt Baker
Benjamin Mangus
Aaron Arvidson
Journey Service Center
James Gilligan
Erin Witter
Natasha Campbell
Darryl Hudson
Bart van Huizum
Mary Bernitt
Alex Kenyon
A Discussion with Measure 109 Campaign Team
Sep 03, 2020
PSYCHEDELICS AS MEDICINE
Making MDMA and Psilocybin-assisted therapies available in Australia- How to Access These Medicines Today to Treat Those With Serious Mental Illness
Sep 09, 2020
Beyond Peak Experiences: An Integrated Approach to Psychedelic Use With Stefana Bosse and Ciara Sherlock / Women in Psychedelics Series
Sep 10, 2020
Psychedelic Writing and the Language of Mushrooms
Nov 04, 2020
The Shadow of Mainstreaming Psychedelics
Nov 23, 2020
Psilocybin Versus SSRIs? A Cure for Depression
Mar 24, 2021
Episode 15: Psilocybin Mushrooms vs. Psilocybin: The Dialectic Between Nature vs. Synthetic
Dec 29, 2020
Drug Policy: From Illegal To Medical
Jan 06, 2021
Psilocybin-assisted Therapy for End-of-Life Distress
Apr 28, 2021
WWC Conference- FREE global conference
May 26, 2021
Microdosing Mushrooms Conference
Nov 19, 2023
A Study of Psilocybin for Major Depressive Disorder (MDD)
UW Psilocybin Pharmacokinetics Study
Effects of Psilocybin in Anorexia Nervosa
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Psilocybin for Treatment of Obsessive Compulsive Disorder
Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
Persisting Effects of Psilocybin
Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
Psilocybin for the Treatment of Migraine Headache
The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
Repeat Dosing of Psilocybin in Migraine Headache
An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms
Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients
Prophylactic Effects of Psilocybin on Chronic Cluster Headache
Effects of Psilocybin in Concussion Headache
Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
Psilocybin and Depression
The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals
Effects of Psilocybin in Major Depressive Disorder
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
Adjunctive Effects of Psilocybin and Buprenorphine
Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion
Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept
Visual Surround Suppression and Perceptual Expectation Under Psilocybin
Psilocybin-facilitated Treatment for Cocaine Use
Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Psilocybin for the Treatment of Cluster Headache
Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma
Psychopharmacology of Psilocybin in Cancer Patients
Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Psilocybin Cancer Anxiety Study
A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence
Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin
Comparative Acute Effects of LSD, Psilocybin and Mescaline
The Neurobiological Effect of 5-HT2AR Modulation
Psilocybin and Spiritual Practice
Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects
PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self
LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders
Effects of Hallucinogens and Other Drugs on Mood and Performance
Precision Functional Brain Mapping in Psilocybin
Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer
The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
Psilocybin for Psychological and Existential Distress in Palliative Care
The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression
Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy
Psilocybin-assisted CBT for Depression
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder
Psilocybin Therapy for Depression in Bipolar II Disorder
The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder
Frontline Clinician Psilocybin Study
Psilocybin for Treatment-Resistant Depression
Exploratory Study of Low Dose Psilocybin
Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use
Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain
Psilocybin-assisted Therapy for Phantom Limb Pain
Psilocybin-facilitated Treatment for Chronic Pain
Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD
Pilot RECAP Study in Healthy Volunteers
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
Mood and Cognitive Effects of Psilocybin in Healthy Participants
Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)
Psilocybin in Depression Resistant to Standard Treatments
Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder
Naturalistic Study of Microdosing With Psilocybin
Palliadelic Treatment to Reduce Psychological Distress in Persons With Inoperable Pancreatobiliary Cancer
Northwest Therapies Trauma Psilocybin Study Compassionate Use Study
Microdosing Psychedelics to Improve Mood
Open-label Study to Assess the Safety and Efficacy of TRP-8802 With Psychotherapy in Adult Participants With Fibromyalgia
Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults
Characterization of Altered Waking States of Consciousness in Healthy Humans
Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
Personality and Drug Use (PDU)
Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder
Effects of Psilocybin in Post-Treatment Lyme Disease
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
Effects of Repeated Psilocybin Dosing in OCD
Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
Pragmatic Trial of Psilocybin Therapy in Palliative Care
Comparing the Effects of Psilocin and Psilocybin in Healthy Adults
Psilocybin Therapy in Advanced Cancer
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
Psilocybin Therapy for Chronic Low Back Pain
Psilocybin Versus Ketamine in Treatment-Resistant Depression
A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder
Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder
Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects
The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
Lysergic Acid Diethylamide (LSD) in Palliative Care
Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
Effects of Psilocybin in Obsessive Compulsive Disorder
An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics
Bioavailability Study of Psilocybin in Normal Adults
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Major Depressive Disorder With One Prior Treatment Failure
Evaluation of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans
Neural and Physiological Correlates of Psychedelic Sub-states
Psilocybin-assisted Interpersonal Therapy for Depression
Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action
PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout
Psilocybin in Adults With and Without Autism Spectrum Disorder
Efficacy, Safety, and Tolerability of a Single Administration of COMP360 in Participants With TRD
Psilocybin in Cancer Pain Study
Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study
Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication
Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment
Effect of SSRIs on Response to Psilocybin Therapy
Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer
Psilocybin in Functional Neurological Disorder
A Community of Practice Program With Psilocybin-assisted Therapy for End-of-Life Patients
Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder
PET Synaptogenesis After Psilocybin In DEpression Recovery
An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X Syndrome
Consciousness, Psilocybin, and Well-Being
Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)
Does Psilocybin Require Psychedelic Effects to Treat Depression?
Psilocybin for Major Depressive Disorder
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer
Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain
Pairing Psilocybin With Transauricular Vagus Nerve Stimulation
The pharmacology of psilocybin
T Passie, J Seifert, U Schneider, HM Emrich - Addiction biology, 2002 - Wiley Online Library
Response of cluster headache to psilocybin and LSD
RA Sewell, JH Halpern, HG Pope - Neurology, 2006 - AAN Enterprises
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
RR Griffiths, WA Richards, U McCann, R Jesse - Psychopharmacology, 2006 - Springer
Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study
MP Bogenschutz, AA Forcehimes… - Journal of …, 2015 - journals.sagepub.com
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
FX Vollenweider… - …, 1998 - journals.lww.com
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer
CS Grob, AL Danforth, GS Chopra… - Archives of general …, 2011 - jamanetwork.com
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
RR Griffiths, MW Johnson, WA Richards… - …, 2011 - Springer
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
RL Carhart-Harris, D Erritzoe… - Proceedings of the …, 2012 - National Acad Sciences
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
RL Carhart-Harris, L Roseman, M Bolstridge… - Scientific reports, 2017 - nature.com
Cross tolerance between LSD and psilocybin
H Isbell, AB Wolbach, A Wikler, EJ Miner - Psychopharmacologia, 1961 - Springer
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
RL Carhart-Harris, M Bolstridge, J Rucker, CMJ Day… - The Lancet …, 2016 - Elsevier
Long-term follow-up of psilocybin-facilitated smoking cessation
MW Johnson, A Garcia-Romeu… - The American journal of …, 2017 - Taylor & Francis
Prediction of psilocybin response in healthy volunteers
E Studerus, A Gamma, M Kometer, FX Vollenweider - PloS one, 2012 - journals.plos.org
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
KA MacLean, MW Johnson… - Journal of …, 2011 - journals.sagepub.com
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
FA Moreno, CB Wiegand, EK Taitano… - Journal of Clinical …, 2006 - wiki.dmt-nexus.me
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
RL Carhart-Harris, M Bolstridge, CMJ Day, J Rucker… - …, 2018 - Springer
Potential therapeutic effects of psilocybin
MW Johnson, RR Griffiths - Neurotherapeutics, 2017 - Springer
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
MW Johnson, A Garcia-Romeu… - Journal of …, 2014 - journals.sagepub.com
Reactions to psilocybin administered in a supportive environment.
T Leary, GH Litwin, R Metzner - Journal of Nervous and Mental …, 1963 - psycnet.apa.org
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
RR Griffiths, WA Richards… - Journal of …, 2008 - journals.sagepub.com
Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction
A Garcia-Romeu, RR Griffiths… - Current drug abuse …, 2014 - ingentaconnect.com
Enzymatic synthesis of psilocybin
J Fricke, F Blei, D Hoffmeister - … Chemie International Edition, 2017 - Wiley Online Library
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
S Ross, A Bossis, J Guss… - Journal of …, 2016 - journals.sagepub.com
Effects of psilocybin therapy on personality structure
D Erritzoe, L Roseman, MM Nour… - Acta Psychiatrica …, 2018 - Wiley Online Library
Biosynthesis of psilocybin
S Agurell, JGL Nilsson - Acta Chem. Scand, 1968 - thevespiary.org
Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin
RL Carhart-Harris, R Leech, TM Williams… - The British Journal of …, 2012 - cambridge.org
Comparison of the reactions induced by psilocybin and LSD-25 in man
H Isbell - Psychopharmacologia, 1959 - Springer
Psilocybin–summary of knowledge and new perspectives
F Tylš, T Páleníček, J Horáček - European Neuropsychopharmacology, 2014 - Elsevier
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis
FX Vollenweider, KL Leenders, C Scharfetter… - …, 1997 - nature.com
Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression
L Roseman, DJ Nutt, RL Carhart-Harris - Frontiers in Pharmacology, 2018 - frontiersin.org
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
RR Griffiths, MW Johnson… - Journal of …, 2016 - journals.sagepub.com
Mescaline, LSD, Psilocybin, and Personality Change a Review
SML Unger - Psychiatry, 1963 - Taylor & Francis
Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis
RL Carhart-Harris, R Leech, D Erritzoe… - Schizophrenia …, 2013 - academic.oup.com
Effects of psilocybin on time perception and temporal control of behaviour in humans
M Wittmann, O Carter, F Hasler… - Journal of …, 2007 - journals.sagepub.com
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA
MC Mithoefer, CS Grob, TD Brewerton - The Lancet Psychiatry, 2016 - Elsevier
Patients' accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression
R Watts, C Day, J Krzanowski, D Nutt… - Journal of …, 2017 - journals.sagepub.com
Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
MM Schartner, RL Carhart-Harris, AB Barrett, AK Seth… - Scientific reports, 2017 - nature.com
Patient experiences of psilocybin-assisted psychotherapy: an interpretative phenomenological analysis
AB Belser, G Agin-Liebes, TC Swift… - Journal of …, 2017 - journals.sagepub.com
Increased activation of indirect semantic associations under psilocybin
M Spitzer, M Thimm, L Hermle… - Biological …, 1996 - biologicalpsychiatryjournal.com
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
E Studerus, M Kometer, F Hasler… - Journal of …, 2011 - journals.sagepub.com
The occurrence of psilocybin in Gymnopilus species
GM Hatfield, LJ Valdes - Lloydia, 1978 - safetylit.org
Psilocybin: Magic Mushroom Grower's Guide: A Handbook for Psilocybin Enthusiasts
OT Oss, ON Oeric - 1992 - books.google.com
Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers
R Kraehenmann, KH Preller, M Scheidegger… - Biological …, 2015 - Elsevier
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study
F Hasler, U Grimberg, MA Benz, T Huber… - …, 2004 - Springer
5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man—a PET study with raclopride
FX Vollenweider, P Vontobel, D Hell… - …, 1999 - nature.com
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
FS Barrett, MW Johnson… - Journal of …, 2015 - journals.sagepub.com
Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin
KA MacLean, JMS Leoutsakos… - Journal for the …, 2012 - Wiley Online Library
Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors
OL Carter, DC Burr, JD Pettigrew, GM Wallis… - Journal of Cognitive …, 2005 - MIT Press
Psilocybin, psychological distress, and suicidality
PS Hendricks, MW Johnson… - Journal of …, 2015 - journals.sagepub.com
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
MK Madsen, PM Fisher, D Burmester… - …, 2019 - nature.com
Finding the self by losing the self: Neural correlates of ego‐dissolution under psilocybin
AV Lebedev, M Lövdén, G Rosenthal… - Human brain …, 2015 - Wiley Online Library
Psilocybin Mushroom (Psilocybe semilanceata) Intoxication with Myocardial Infarction
KS Borowiak, K Ciechanowski… - Journal of Toxicology …, 1998 - Taylor & Francis
The effects of psilocybin on primary process content in language.
C Martindale, R Fischer - Confinia psychiatrica, 1977 - psycnet.apa.org
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
L Roseman, L Demetriou, MB Wall, DJ Nutt… - …, 2018 - Elsevier
Effects of LSD-25, psilocybin and psilocin on temporal lobe EEG patterns & learned behavior in the cat.
WR Adey, FR Bell, BJ Dennis - Neurology, 1962 - psycnet.apa.org
Effect of psilocybin on empathy and moral decision-making
T Pokorny, KH Preller, M Kometer… - International Journal …, 2017 - academic.oup.com
Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin
LD Lord, P Expert, S Atasoy, L Roseman, K Rapuano… - Neuroimage, 2019 - Elsevier
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
TM Carbonaro, MP Bradstreet… - Journal of …, 2016 - journals.sagepub.com
Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations
M Kometer, A Schmidt, L Jäncke… - Journal of …, 2013 - Soc Neuroscience
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
L Smigielski, M Scheidegger, M Kometer… - NeuroImage, 2019 - Elsevier
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
MW Johnson, RR Griffiths, PS Hendricks… - …, 2018 - Elsevier
Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception
AM Hartman, LE Hollister - Psychopharmacologia, 1963 - Springer
Psilocybin impairs high-level but not low-level motion perception
OL Carter, JD Pettigrew, DC Burr, D Alais, F Hasler… - …, 2004 - journals.lww.com
Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors
M Kometer, A Schmidt, R Bachmann, E Studerus… - Biological …, 2012 - Elsevier
Baeocystin and norbaeocystin: new analogs of psilocybin from Psilocybe baeocystis
AY Leung, AG Paul - Journal of Pharmaceutical Sciences, 1968 - Elsevier
The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers
L Roseman, R Leech, A Feilding, DJ Nutt… - Frontiers in human …, 2014 - frontiersin.org
Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers
MW Johnson, RA Sewell, RR Griffiths - Drug and alcohol dependence, 2012 - Elsevier
Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
BJ Catlow, S Song, DA Paredes, CL Kirstein… - Experimental brain …, 2013 - Springer
Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans
OL Carter, F Hasler, JD Pettigrew, GM Wallis… - …, 2007 - Springer
Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers
BB Quednow, M Kometer, MA Geyer… - …, 2012 - nature.com
The psilocybin mushroom pandemic
SH Pollock - Journal of Psychedelic Drugs, 1975 - Taylor & Francis
The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval
FX Vollenweider, PA Csomor, B Knappe… - …, 2007 - nature.com
Dephosphorylation of psilocybin in the intact mouse
A Horita, LJ Weber - Toxicology and Applied Pharmacology, 1962 - Elsevier
Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression
T Lyons, RL Carhart-Harris - Journal of Psychopharmacology, 2018 - journals.sagepub.com
Psilocybin-induced stimulus control in the rat
JC Winter, KC Rice, DJ Amorosi, RA Rabin - … Biochemistry and Behavior, 2007 - Elsevier
The enzymic dephosphorylation and oxidation of psilocybin and pscilocin by mammalian tissue homogenates
A Horita, LJ Weber - Biochemical Pharmacology, 1961 - Elsevier
Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans
E Gouzoulis-Mayfrank, K Heekeren… - Behavioural …, 1998 - journals.lww.com
Production of psilocybin in Psilocybe baeocystis saprophytic culture
AY Leung, AH Smith, AG Paul - Journal of Pharmaceutical …, 1965 - Wiley Online Library
The relationship between the metabolic fate and pharmacological actions of serotonin, bufotenine and psilocybin
PK Gessner, PA Khairallah, WM McIsaac… - Journal of Pharmacology …, 1960 - ASPET
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological …
RR Griffiths, MW Johnson… - Journal of …, 2018 - journals.sagepub.com
Sub-acute effects of psilocybin on empathy, creative thinking, and subjective well-being
NL Mason, E Mischler, MV Uthaug… - Journal of psychoactive …, 2019 - Taylor & Francis
Serotonin, psilocybin, and body dysmorphic disorder: a case report
KR Hanes - J Clin Psychopharmacol, 1996 - erowid.org
DARK classics in chemical neuroscience: Psilocybin
HA Geiger, MG Wurst, RN Daniels - ACS chemical neuroscience, 2018 - ACS Publications
Neurometabolic effects of psilocybin, 3, 4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers: a double-blind, placebo-controlled …
E Gouzoulis-Mayfrank, M Schreckenberger… - …, 1999 - Elsevier
Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations
M Kometer, T Pokorny, E Seifritz, FX Volleinweider - Psychopharmacology, 2015 - Springer
SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist
H Sard, G Kumaran, C Morency, BL Roth… - Bioorganic & medicinal …, 2005 - Elsevier
Some observations on psilocybin, a new hallucinogen, in volunteer subjects.
S Malitz, H Esecover, B Wilkens… - Comprehensive …, 1960 - psycnet.apa.org
Effects of varied doses of psilocybin on time interval reproduction in human subjects
J Wackermann, M Wittmann, F Hasler… - Neuroscience …, 2008 - Elsevier
Occurrence of psilocybin in various higher fungi from several European countries
T Stijve, TW Kuyper - Planta medica, 1985 - academia.edu
Hallucinogen persisting perception disorder after psilocybin consumption: a case study
ML Espiard, L Lecardeur, P Abadie, I Halbecq… - European …, 2005 - Elsevier
Psychopathological, neuroendocrine and autonomic effects of 3, 4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy …
E Gouzoulis-Mayfrank, B Thelen, E Habermeyer… - …, 1999 - Springer
Mescaline, lysergic acid diethylamide and psilocybin: comparison of clinical syndromes, effects on color perception and biochemical measures
LE Hollister, AM Hartman - Comprehensive Psychiatry, 1962 - Elsevier
Occurrence of psilocybin and psilocin in certain Gonocybe and Psilocybe species.
RG Benedict, LR Brady, AH Smith, VE Tyler - Lloydia, 1962 - cabdirect.org
Effects of the 5-HT 2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of …
D Umbricht, FX Vollenweider, L Schmid… - …, 2003 - nature.com
Occurrence of Psilocybin/Psilocin in Pluteus Salicinus (Pluteaceae)
SG Saupe - Mycologia, 1981 - Taylor & Francis
Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2, 4, 5-trimethoxyamphetamine
ROYW BAKER, C CHOTHIA… - Molecular …, 1973 - modul.repo.mercubuana-yogya.ac.id
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
FS Barrett, MP Bradstreet… - Journal of …, 2016 - journals.sagepub.com
The production of psilocybin in submerged culture by Psilocybe cubensis
P Catalfomo, VE Tyler - Lloydia, 1964 - en.psilosophy.info
Persistent psychiatric symptoms after eating psilocybin mushrooms.
C Benjamin - British medical journal, 1979 - ncbi.nlm.nih.gov
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the …
RG Dos Santos, FL Osório, JAS Crippa… - Therapeutic …, 2016 - journals.sagepub.com
Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, USA
MW Beug, J Bigwood - Journal of ethnopharmacology, 1982 - Elsevier
GLC‐mass spectral analysis of psilocin and psilocybin
DB Repke, DT Leslie, DM Mandell… - Journal of …, 1977 - Wiley Online Library
Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance
RJ Dinis-Oliveira - Drug Metabolism Reviews, 2017 - Taylor & Francis
Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man
F Hasler, D Bourquin, R Brenneisen, T Bär… - Pharmaceutica Acta …, 1997 - Elsevier
The problem of psilocybin mushroom abuse
NR Peden, SD Pringle, J Crooks - Human toxicology, 1982 - journals.sagepub.com
Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man
F Hasler, D Bourquin, R Brenneisen… - … of pharmaceutical and …, 2002 - Elsevier
Determination of psilocybin in Psilocybe semilanceata using high-performance liquid chromatography on a silica column
AL Christiansen, KE Rasmussen… - … of Chromatography A, 1981 - psilosybiini.info
Dephosphorylation of psilocybin to psilocin by alkaline phosphatase
A Horita, LJ Weber - … of the society for experimental biology …, 1961 - journals.sagepub.com
Isolation of psilocybin from Psilocybe argentipes and its determination in specimens of some mushrooms
Y Koike, K Wada, G Kusano, S Nozoe… - Journal of Natural …, 1981 - ACS Publications
Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow
CR Lewis, KH Preller, R Kraehenmann, L Michels… - Neuroimage, 2017 - Elsevier
Pharmacokinetics of escalating doses of oral psilocybin in healthy adults
RT Brown, CR Nicholas, NV Cozzi, MC Gassman… - Clinical …, 2017 - Springer
Psilocybin for treating substance use disorders?
BTH De Veen, AFA Schellekens… - Expert review of …, 2017 - Taylor & Francis
Personality trait dependent performance under psilocybin.
R Fischer, T Kappeler, P Wisecup… - Diseases of the nervous …, 1970 - psycnet.apa.org
The occurrence of psilocybin and psilocin in Finnish Fungi
E Ohenoja, J Jokiranta, T Mäkinen… - Journal of natural …, 1987 - ACS Publications
Inter-relations of the effects of psilocybin on subjective sensation, photopic critical frequency of fusion, and circulating non-esterified fatty acids
MH Keeler - Experientia, 1963 - Springer
… experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT
RR Griffiths, ES Hurwitz, AK Davis, MW Johnson… - PloS one, 2019 - journals.plos.org
Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT 2A and 5-HT 1A agonist psilocybin
OL Carter, JD Pettigrew, F Hasler, GM Wallis… - …, 2005 - nature.com
Psilocybin-induced contraction of nearby visual space
R Fischer, R Hill, K Thatcher, J Scheib - Agents and actions, 1970 - Springer
Production options for psilocybin: making of the magic
J Fricke, C Lenz, J Wick, F Blei… - Chemistry–A European …, 2019 - Wiley Online Library
The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations
M Kometer, BR Cahn, D Andel, OL Carter… - Biological …, 2011 - Elsevier
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences
TM Carbonaro, MW Johnson, E Hurwitz… - Psychopharmacology, 2018 - Springer
Comparison of three psychotropic drugs (psilocybin, JB-329, and IT-290) in volunteer subjects
LE Hollister, JJ PRUSMACK… - The Journal of …, 1960 - journals.lww.com
The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
R Kraehenmann, A Schmidt, K Friston, KH Preller… - NeuroImage: Clinical, 2016 - Elsevier
Changes in spider webs brought about by mescaline, psilocybin and an increase in body weight
A Christiansen, R Baum, PN Witt - Journal of Pharmacology and …, 1962 - Citeseer
Analysis of psilocybin and psilocin in Psilocybe subcubensis GUZMAN by ion mobility spectrometry and gas chromatography–mass spectrometry
T Keller, A Schneider, P Regenscheit… - Forensic science …, 1999 - Elsevier
Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
JB Stroud, TP Freeman, R Leech, C Hindocha… - …, 2018 - Springer
Concise large-scale synthesis of psilocin and psilocybin, principal hallucinogenic constituents of “magic mushroom”
O Shirota, W Hakamata, Y Goda - Journal of natural products, 2003 - ACS Publications
Occurrence of psilocybin and baeocystin in the genus Inocybe (Fr.) Fr
T Stijve, J Klan, TW Kuyper - Persoonia-Molecular Phylogeny …, 1985 - repository.naturalis.nl
Quantitative analysis of psilocybin and psilocin and psilocybe baecystis (singer and smith) by high-performance liquid chromatography and by thin-layer …
MW Beug, J Bigwood - Journal of Chromatography A, 1981 - Elsevier
Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications
C Hyde, G Glancy, P Omerod, D Hall… - The British Journal of …, 1978 - cambridge.org
Occurrence of psilocybin, psilocin and baeocystin in Gymnopilus purpuratus
J Gartz - Persoonia-Molecular Phylogeny and Evolution of …, 1989 - repository.naturalis.nl
A new behavior change program using psilocybin
T Leary, R Metzner, M Presnell, GM Weil… - 1965 - psycnet.apa.org
Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans
E Gouzoulis-Mayfrank, B Thelen, S Maier… - …, 2002 - karger.com
Baeocystin, a mono-methyl analog of psilocybin from Psilocybe baeocystis saprophytic culture
AY Leung, AG Paul - Journal of pharmaceutical sciences, 1967 - jpharmsci.org
The content of psilocybin in Norwegian Psilocybe semilanceata
AL Christiansen, KE Rasmussen, K Høiland - Planta medica, 1981 - thieme-connect.com
Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat
L Smigielski, M Kometer, M Scheidegger… - Scientific reports, 2019 - nature.com
Effect of Psilocybin, LSD, and mescaline on small, involuntary eye movements
FW Hebbard, R Fischer - Psychopharmacologia, 1966 - Springer
Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination
O Grimm, R Kraehenmann, KH Preller, E Seifritz… - European …, 2018 - Elsevier
Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom Inocybe aeruginascens
N Jensen, J Gartz, H Laatsch, F Biotransformations - Planta medica, 2006 - Citeseer
Determination of psilocybin in Psilocybe semilanceata by capillary zone electrophoresis
S Pedersen-Bjergaard, E Sannes… - … of Chromatography B …, 1997 - Elsevier
Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and‡9-THC using the micronucleus test
GF Van Went - Experientia, 1978 - Springer
Role of psilocybin in the treatment of depression
A Mahapatra, R Gupta - Therapeutic advances in …, 2017 - journals.sagepub.com
The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis
SB Goldberg, BT Pace, CR Nicholas, CL Raison… - Psychiatry …, 2020 - Elsevier
Return of the psychedelics: Psilocybin for treatment resistant depression
S Patra - Asian Journal of Psychiatry, 2016 - Elsevier
Neuroticism is associated with challenging experiences with psilocybin mushrooms
FS Barrett, MW Johnson, RR Griffiths - Personality and individual …, 2017 - Elsevier
Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study
J Barsuglia, AK Davis, R Palmer, R Lancelotta… - Frontiers in …, 2018 - frontiersin.org
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
GI Agin-Liebes, T Malone, MM Yalch… - Journal of …, 2020 - journals.sagepub.com
The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions
A Schmidt, M Kometer, R Bachmann, E Seifritz… - …, 2013 - Springer
The quantitation of psilocybin in hallucinogenic mushrooms using high performance liquid chromatography
SM Sottolano, IS Lurie - Journal of Forensic Science, 1983 - astm.org
Psilocybin-assisted therapy: a review of a novel treatment for psychiatric disorders
K Thomas, B Malcolm, D Lastra - Journal of Psychoactive Drugs, 2017 - Taylor & Francis
Some biochemical studies on psilocybin and psilocin
A Horita - 1962 - apps.dtic.mil
Use of the classic hallucinogen psilocybin for treatment of existential distress associated with cancer
CS Grob, AP Bossis, RR Griffiths - Psychological aspects of cancer, 2013 - Springer
More realistic forecasting of future life events after psilocybin for treatment-resistant depression
T Lyons, RL Carhart-Harris - Frontiers in psychology, 2018 - frontiersin.org
Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis (Earle) Singer
J Bigwood, MW Beug - Journal of ethnopharmacology, 1982 - Elsevier
In vivo production of psilocybin in E. coli
AM Adams, NA Kaplan, Z Wei, JD Brinton… - Metabolic …, 2019 - Elsevier
Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen
A Hofmann, R Heim, A Brack, H Kobel… - Helvetica Chimica …, 1959 - Wiley Online Library
Analysis of psilocybin and psilocin in mushroom extracts by reversed-phase high performance liquid chromatography
BM Thomson - Journal of Forensic Science, 1980 - astm.org
The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary …
RL Carhart-Harris, TM Williams… - Journal of …, 2011 - journals.sagepub.com
Cancer at the dinner table: experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress
TC Swift, AB Belser, G Agin-Liebes… - Journal of …, 2017 - journals.sagepub.com
Clinical syndromes and biochemical alterations following mescaline, lysergic acid diethylamide, psilocybin and a combination of the three psychotomimetic drugs
LE Hollister, BM Sjoberg - Comprehensive Psychiatry, 1964 - Elsevier
Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen RauschpilzPsilocybe mexicana Heim
A Hofmann, R Heim, A Brack, H Kobel - Experientia, 1958 - Springer
Ethnobotany of psilocybin mushrooms, especially Psilocybe cubensis
ER Badham - Journal of ethnopharmacology, 1984 - psilosybiini.info
Production of cross-tolerance to psychosis-producing doses of lysergic acid diethylamide and psilocybin
HA Abramson, A Rolo, B Sklarofsky… - The Journal of …, 1960 - Taylor & Francis
Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame
J Sloshower, J Guss, R Krause, RM Wallace… - Journal of Contextual …, 2020 - Elsevier
Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase‐Enhanced Reactions
F Blei, F Baldeweg, J Fricke… - Chemistry–A European …, 2018 - Wiley Online Library
Detection of psilocybin and psilocin in Norwegian species of Pluteus and Conocybe
AL Christiansen, KE Rasmussen, K Høiland - Planta medica, 1984 - thieme-connect.com
Psilocybin and obsessive compulsive disorder
JA Wilcox - Journal of psychoactive drugs, 2014 - Taylor & Francis
Psilocybin in Finnish Psilocybe semilanceata
J Jokiranta, S Mustola, E Ohenoja… - Planta …, 1984 - thieme-connect.com
Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi
P Kosentka, SL Sprague, M Ryberg, J Gartz, AL May… - PloS one, 2013 - journals.plos.org
Improvements to the synthesis of psilocybin and a facile method for preparing the O-acetyl prodrug of psilocin
DE Nichols, S Frescas - Synthesis, 1999 - thevespiary.org
Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner
M Lyvers, M Meester - Journal of psychoactive drugs, 2012 - Taylor & Francis
A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment
S Turton, DJ Nutt… - Current Drug Abuse …, 2014 - ingentaconnect.com
Psilocybin: biphasic dose-response effects on the acoustic startle reflex in the rat
M Davis, JK Walters - Pharmacology Biochemistry and Behavior, 1977 - Elsevier
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: mechanism of action and potential therapeutic applications in mood disorders
D De Gregorio, JP Enns, NA Nuñez, L Posa… - Progress in brain …, 2018 - Elsevier
Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids
C Andersson, J Kristinsson, J Gry - 2009 - books.google.com
Handling of psilocybin and psilocin by everted sacs of rat jejunum and colon.
K Eivindvik, KE Rasmussen, RB Sund - Acta pharmaceutica nordica, 1989 - europepmc.org
Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant …
LJ Mertens, MB Wall, L Roseman… - Journal of …, 2020 - journals.sagepub.com
Psilocybin and MDMA reduce costly punishment in the Ultimatum Game
AS Gabay, RL Carhart-Harris, N Mazibuko… - Scientific reports, 2018 - nature.com
The phenomenology and potential religious import of states of consciousness facilitated by psilocybin
W Richards - Archive for the Psychology of Religion, 2008 - brill.com
Emotions and brain function are altered up to one month after a single high dose of psilocybin
FS Barrett, MK Doss, ND Sepeda, JJ Pekar… - Scientific reports, 2020 - nature.com
Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat
O Jefsen, K Højgaard, SL Christiansen… - Acta …, 2019 - cambridge.org
Scalable hybrid synthetic/biocatalytic route to psilocybin
J Fricke, R Kargbo, L Regestein, C Lenz… - … A European Journal, 2020 - Wiley Online Library
THE HALLUCINOGENIC MUSHROOMS OF MEXICO AND PSILOCYBIN: A BIBLIOGRAPHY (Second printing, with corrections and addenda)
RG Wasson - Botanical Museum Leaflets, Harvard University, 1963 - JSTOR
Psilocybin induces time-dependent changes in global functional connectivity
KH Preller, P Duerler, JB Burt, JL Ji, B Adkinson… - Biological …, 2020 - Elsevier
Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin
F Bernasconi, A Schmidt, T Pokorny, M Kometer… - Cerebral …, 2014 - academic.oup.com
A novel extraction procedure for psilocybin and psilocin determination in mushroom samples.
R Kysilka, M Wurst - Planta medica, 1990 - cabdirect.org
Monoamine biosynthesis via a noncanonical calcium-activatable aromatic amino acid decarboxylase in psilocybin mushroom
MP Torrens-Spence, CT Liu, T Pluskal… - ACS chemical …, 2018 - ACS Publications
Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin
MP Bogenschutz - Current drug abuse reviews, 2013 - ingentaconnect.com
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition
FS Barrett, TM Carbonaro, E Hurwitz, MW Johnson… - …, 2018 - Springer
Clinical interpretations of patient experience in a trial of psilocybin-assisted psychotherapy for alcohol use disorder
MP Bogenschutz, SK Podrebarac, JH Duane… - Frontiers in …, 2018 - frontiersin.org
Psilocybin in Mycelkulturen von Inocybe aeruginascens
J Gartz - Biochemie und Physiologie der Pflanzen, 1986 - Elsevier
Konstitutionsaufklärung und synthese von psilocybin
A Hofmann, A Frey, H Ott, T Petrzilka, F Troxler - Experientia, 1958 - Springer
Replication and extension of a model predicting response to psilocybin
SL Russ, RL Carhart-Harris, G Maruyama… - Psychopharmacology, 2019 - Springer
Psilocybin-induced autonomic, perceptual, and behavioral change
R Fischer, D Warshay - Pharmacopsychiatry, 1968 - thieme-connect.com
Comparison of the discriminative stimulus properties of Δ9-THC and psilocybin in rats
I Greenberg, D Kuhn, JB Appel - Pharmacology Biochemistry and Behavior, 1975 - Elsevier
Psilocybin and Mental Health–Don't Lose Control
JM Barnby, MA Mehta - Frontiers in psychiatry, 2018 - frontiersin.org
Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?
A Whelan, MI Johnson - Pain Management, 2018 - Future Medicine
Effects of psilocybin, dimethyltryptamine, mescaline and various allergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio)
BS Meldrum, R Naquet - Electroencephalography and clinical …, 1971 - Elsevier
Effects of the psychodysleptic drug psilocybin on visual perception. Changes in brightness preference
R Fischer, RM Hill, D Warshay - Experientia, 1969 - Springer
The effects of psilocybin on a test of after-image perception
MH Keeler - Psychopharmacologia, 1965 - Springer
Formation of blue oxidation product from psilocybin
WG Levine - Nature, 1967 - Springer
Psilocybin: good trip or bad trip
EM Sellers - Clinical Pharmacology & Therapeutics, 2017 - Wiley Online Library
A technique for the rapid isolation and identification of psilocin from psilocin/psilocybin-containing mushrooms
RE Lee - Journal of Forensic Science, 1985 - astm.org
Psilocybin-containing mushrooms
SC Smolinske - Handbook of mushroom poisoning—diagnosis …, 1994 - books.google.com
Sacred mushroom of visions: Teonanacatl: A sourcebook on the psilocybin mushroom
R Metzner - 2005 - books.google.com
Determination of psilocybin in hallucinogenic mushrooms by reversed-phase liquid chromatography with fluorescence detection
K Saito, T Toyo'oka, M Kato, T Fukushima, O Shirota… - Talanta, 2005 - Elsevier
Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin
SN Young - Journal of psychiatry & neuroscience: JPN, 2013 - ncbi.nlm.nih.gov
Determination of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris (2, 2′-bipyridyl) ruthenium (II) chemiluminescence …
N Anastos, NW Barnett, SW Lewis, N Gathergood… - Talanta, 2005 - Elsevier
High dose psilocybin is associated with positive subjective effects in healthy volunteers
CR Nicholas, KM Henriquez… - Journal of …, 2018 - journals.sagepub.com
Simultaneous Production of Psilocybin and a Cocktail of β‐Carboline Monoamine Oxidase Inhibitors in “Magic” Mushrooms
F Blei, S Dörner, J Fricke, F Baldeweg… - … A European Journal, 2020 - Wiley Online Library
Absence of psilocybin in species of fungi previously reported to contain psilocybin and related tryptamine derivatives
T Stijve, TW Kuyper - Persoonia-Molecular Phylogeny and …, 1988 - repository.naturalis.nl
Abwandlungsprodukte von Psilocybin und Psilocin. 2. Mitteilung über synthetische Indolverbindungen
F Troxler, F Seemann, A Hofmann - Helvetica Chimica Acta, 1959 - Wiley Online Library
The psilocybin-induced" state of drunkenness" in normal volunteers and schizophrenics.
AJ Parashos - Behavioral neuropsychiatry, 1976 - europepmc.org
Lysergic acid diethylamide and psilocybin revisited
MA Geyer - Biological psychiatry, 2015 - biologicalpsychiatryjournal.com
Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience
CR Lewis, KH Preller, BB Braden, C Riecken… - Biomedicines, 2020 - mdpi.com
Psilocybin Investigator's Brochure
L Jerome - Multidisciplinary Association, 2007 - en.psilosophy.info
Clinical potential of psilocybin as a treatment for mental health conditions
J Daniel, M Haberman - Mental Health Clinician, 2017 - meridian.allenpress.com
An improved, practical, and scalable five-step synthesis of psilocybin
AM Sherwood, P Meisenheimer, G Tarpley… - Synthesis, 2020 - thieme-connect.com
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience
T Pokorny, KH Preller, R Kraehenmann… - European …, 2016 - Elsevier
Metabolic engineering of Saccharomyces cerevisiae for the production of psilocybin and related tryptamine derivatives
N Milne, P Thomsen, NM Knudsen, P Rubaszka… - Metabolic …, 2020 - Elsevier
Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache
M Fanciullacci, G Franchi, F Sicuteri - Experientia, 1974 - Springer
Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'
J Koerner, JB Appel - Psychopharmacology, 1982 - Springer
XXXVIII. Comparison with Action of Methysergide and Psilocybin on Test Subjects
HA Abramson, A Rolo - Journal of Asthma Research, 1965 - Taylor & Francis
Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.
DE Nichols - Psychopharmacology, 2006 - Springer
Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes
V Marcano, AM Méndez, F Castellano… - Journal of …, 1994 - Elsevier
The Determination of Psilocin and Psilocybin in Hallucinogenic Mushrooms by HPLC Utilizing a Dual Reagent Acidic Potassium Permanganate and Tris (2, 2 …
N Anastos, SW Lewis, NW Barnett… - Journal of forensic …, 2006 - Wiley Online Library
An electroencephalographic analysis of personality-dependent performance under psilocybin
K Thatcher, WC Wiederholt, R Fischer - Agents and actions, 1971 - Springer
Memo on the Religious Implications of the Consciousness-Changing Drugs (LSD, Mescalin, Psilocybin)
J Havens - Journal for the scientific study of religion, 1964 - JSTOR
Individual experiences in four cancer patients following psilocybin-assisted psychotherapy
TC Malone, SE Mennenga, J Guss… - Frontiers in …, 2018 - frontiersin.org
Development of a psychotherapeutic model for psilocybin-assisted treatment of alcoholism
MP Bogenschutz… - Journal of Humanistic …, 2017 - journals.sagepub.com
The in vitro inhibitory effect of psilocybin and related compounds on human cholinesterases
EK Zsigmond, VM Foldes, FF Foldes - Psychopharmacologia, 1963 - Springer
Psilocybin in Fruchtkörpern von Inocybe aeruginascens
M Semerdžieva, M Wurst, T Koza, J Gartz - Planta medica, 1986 - thieme-connect.com
Psilocybin intoxication
K Dewhurst - The British Journal of Psychiatry, 1980 - cambridge.org
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
NL Mason, KPC Kuypers, F Müller, J Reckweg… - …, 2020 - nature.com
Listening for the logos: A study of reports of audible voices at high doses of psilocybin.
HJ Beach - 1997 - elibrary.ru
Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography.
N Anastos, NW Barnett, FM Pfeffer… - Science & justice: journal …, 2006 - europepmc.org
Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
F Carrillo, M Sigman, DF Slezak, P Ashton… - Journal of affective …, 2018 - Elsevier
Hypnotic induction of the interference of psilocybin with optically induced spatial distortion
PH Gwynne, R Fischer, RM Hill - Pharmacopsychiatry, 1969 - thieme-connect.com
Zur Pharmakologie von Psilocybin, einem Wirkstoff ausPsilocybe mexicana Heim
H Weidmann, M Taeschler, H Konzett - Experientia, 1958 - Springer
Psilocybin: from ancient magic to modern medicine
DE Nichols - The Journal of Antibiotics, 2020 - nature.com
Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains
TF Varley, R Carhart-Harris, L Roseman, DK Menon… - NeuroImage, 2020 - Elsevier
Peak experiences of psilocybin users and non-users
C Cummins, J Lyke - Journal of psychoactive drugs, 2013 - Taylor & Francis
Availability of websites offering to sell psilocybin spores and psilocybin
JP Lott, DB Marlowe, RF Forman - Journal of psychoactive drugs, 2009 - Taylor & Francis
Bis (4-acetoxy-N, N-dimethyltryptammonium) fumarate: a new crystalline form of psilacetin, an alternative to psilocybin as a psilocin prodrug
AR Chadeayne, JA Golen, DR Manke - … Crystallographica Section E …, 2019 - scripts.iucr.org
Treatment of childhood schizophrenia utilizing LSD and psilocybin
G Fisher - Bulletin du MAPS, 1997 - consciouslibrary.com
Psilocybin occasioned mystical‐type experiences
E James, TL Robertshaw, M Hoskins… - Human …, 2020 - Wiley Online Library
Skinner, Maslow, and psilocybin
RS Gable - Journal of Humanistic Psychology, 1993 - journals.sagepub.com
Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention
FS Barrett, SR Krimmel, R Griffiths, DA Seminowicz… - NeuroImage, 2020 - Elsevier
Psilocybin for depression and anxiety associated with life-threatening illnesses
JD McCorvy, RHJ Olsen, BL Roth - Journal of Psychopharmacology, 2016 - ciis.edu
Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse
MW Meinhardt, C Güngör, I Skorodumov… - …, 2020 - nature.com
Enzymatische Synthese von Psilocybin
J Fricke, F Blei, D Hoffmeister - Angewandte Chemie, 2017 - Wiley Online Library
Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future
D Nutt - 2016 - journals.sagepub.com
The Psilocybin Producer's Guide
A Gottlieb - 1997 - consciouslibrary.com
Psilocybin: Psychotherapy or drug?
G Goodwin - Journal of Psychopharmacology, 2016 - ora.ox.ac.uk
Measurement of handwriting area to pressure ratios during psilocybin-induced hallucinations
R Fischer, T Kappeler, P Wisecup, K Thatcher - Agents and Actions, 1969 - Springer
Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and …
TM Carbonaro, MW Johnson, RR Griffiths - Psychopharmacology, 2020 - Springer
Timothy Leary, Richard Alpert (Ram Dass) and the changing definition of psilocybin
C Wark, JF Galliher - International Journal of Drug Policy, 2010 - Elsevier
Effects of psilocybin, dimethyltryptamine and various lysergic acid derivatives on photically-induced epilepsy in the baboon (Papio papio).
BS Meldrum, R Naquet - British journal of pharmacology, 1970 - ncbi.nlm.nih.gov
Convergent evolution of psilocybin biosynthesis by psychedelic mushrooms
AR Awan, JM Winter, D Turner, WM Shaw, LM Suz… - BioRxiv, 2018 - biorxiv.org
… -mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in “magic mushroom” …
T Kamata, M Nishikawa, M Katagi… - Journal of Forensic …, 2005 - astm.org
Crystal structures of the Teonanácatl hallucinogens. Part I. Psilocybin C 12 H 17 N 2 O 4 P
HP Weber, TJ Petcher - Journal of the Chemical Society, Perkin …, 1974 - pubs.rsc.org
Psilocin, psilocybin, serotonin and urea in Panaeolus cyanescens from various origin
T Stijve - Persoonia-Molecular Phylogeny and Evolution of …, 1992 - repository.naturalis.nl
Self-reported negative outcomes of psilocybin users: A quantitative textual analysis
B Bienemann, NS Ruschel, ML Campos, MA Negreiros… - Plos one, 2020 - journals.plos.org
Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing—study on P300 and mismatch negativity in healthy …
A Bravermanová, M Viktorinová, F Tylš, T Novák… - …, 2018 - Springer
Psilocybin mushroom handbook: easy indoor & outdoor cultivation
LG Nicholas, K Ogame - 2006 - books.google.com
Consumption of psilocybin-containing hallucinogenic mushrooms by young people
JF Lassen, NF Lassen, J Skov - Ugeskrift for laeger, 1992 - ncbi.nlm.nih.gov
Psilocybin: Reaction with a fraction of rat brain
LP Gilmour, RD O'Brien - Science, 1967 - science.sciencemag.org
Time Contraction and Psychomotor Performance produced by 'Psilocybin'
R Fischer, EL Mead - Nature, 1966 - Springer
It's time to take psilocybin seriously as a possible treatment for substance use disorders
MP Bogenschutz - The American journal of drug and alcohol …, 2017 - Taylor & Francis
Controlled sensory input: A note on the technic of drug evaluation with a preliminary report on a comparative study of sernyl, psilocybin, and LSD-25
JC Pollard, C Bakker, L Uhr, DF Feuerfile - Comprehensive Psychiatry, 1960 - Elsevier
Psilocybin-Induced Transformations of Visual Space
RM Hill, R Fischer - Pharmacopsychiatry, 1970 - thieme-connect.com
Psilocybin and palliative end-of-life care
RC Shelton, PS Hendricks - Journal of Psychopharmacology, 2016 - ciis.edu
A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding
MK Madsen, PMD Fisher, DS Stenbæk… - European …, 2020 - Elsevier
The effects of THC and psilocybin on paranormal phenomena
DJ Bierman - … Conference on Plants, Shamanism, and States of …, 1998 - researchgate.net
Psilocybin-assisted psychotherapy for dying cancer patients–aiding the final trip
D Spiegel - Journal of Psychopharmacology, 2016 - journals.sagepub.com
Levels of psilocybin and psilocin in various types of mushrooms
J Stríbrný, J Borovicka, M Sokol - Soudni lekarstvi, 2003 - ncbi.nlm.nih.gov
Enzymatic route toward 6‐methylated baeocystin and psilocybin
J Fricke, A Sherwood, R Kargbo, A Orry, F Blei… - …, 2019 - researchgate.net
Comparison of psilocin with psilocybin, mescaline and LSD-25
AB Wolbach, EJ Miner, H Isbell - Psychopharmacologia, 1962 - Springer
Comparative effects of the administration of Taraxein, D-LSD, mescaline, and psilocybin to human volunteers
F Silva, RG Heath, T Rafferty, R Johnson… - Comprehensive …, 1960 - Elsevier
Psilocybin mushrooms of the world: an identification guide
P Stamets - 1996 - sidalc.net
Hallucinogenic Drug-Induced Behavior Under Sensory Attenuation: Prediction of Response to Psilocybin
Y Panton, R Fischer - Archives of General Psychiatry, 1973 - jamanetwork.com
Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016
JB Leonard, B Anderson… - Journal of …, 2018 - journals.sagepub.com
Psilocybin-induced altered states of consciousness: Tolerability, assessment, and prediction
E Studerus - 2013 - edoc.unibas.ch
Induction and extinction of psilocybin induced transformations of visual space
RM Hill, R Fischer - Pharmacopsychiatry, 1973 - thieme-connect.com
Psilocybin, lysergic acid diethylamide, mescaline, and drug-induced synesthesia
B Brogaard, DE Gatzia - … of Drug Addictions and Substance Misuse, 2016 - Elsevier
Psilocybin-assisted therapy for depression: How do we advance the field?
SE Meikle, P Liknaitzky, SL Rossell… - Australian & New …, 2020 - journals.sagepub.com
Lysergic acid diethylamide (LSD-25): XXXIV. Comparison with effect of psilocybin on the Siamese fighting fish
HA Abramson, HH Gettner, A Rolo… - The Journal of …, 1963 - Taylor & Francis
S‐Adenosyl‐l‐Methionine Salvage Impacts Psilocybin Formation in “Magic” Mushrooms
R Demmler, J Fricke, S Dörner, M Gressler… - …, 2020 - Wiley Online Library
Psilocybin research at Johns Hopkins: A 2014 report
R Jesse, RR Griffiths - … paths to spirituality and to god, 2014 - pdfs.semanticscholar.org
Psychedelic medicine: the healing powers of LSD, MDMA, psilocybin, and ayahuasca
RL Miller - 2017 - books.google.com
Psilocybin in end of life care: Implications for further research
P Summergrad - Journal of Psychopharmacology, 2016 - ciis.edu
Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A …
K Heuschkel, KPC Kuypers - Frontiers in Psychiatry, 2020 - ncbi.nlm.nih.gov
Research on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in mice
O Zhuk, I Jasicka-Misiak, A Poliwoda, A Kazakova… - Toxins, 2015 - mdpi.com
What psilocybin taught me about dying
AL Back - Journal of palliative medicine, 2019 - liebertpub.com
Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms
I Morita, H Oyama, Y Kiguchi, A Oguri… - … of Pharmaceutical and …, 2020 - Elsevier
Altered states: psilocybin for treatment-resistant depression
P Cowen - The Lancet Psychiatry, 2016 - thelancet.com
Psychedelic and nonpsychedelic LSD and psilocybin for cluster headache
WJ Davenport - CMAJ, 2016 - Can Med Assoc
The Psilocybin Solution: The role of sacred mushrooms in the quest for meaning
SG Powell - 2011 - books.google.com
The role of psychedelics in palliative care reconsidered: A case for psilocybin
B Kelmendi, P Corlett, M Ranganathan… - Journal of …, 2016 - journals.sagepub.com
Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin
RB Kargbo, A Sherwood, A Walker, NV Cozzi… - ACS …, 2020 - ACS Publications
On travels in the universe of the soul: reports on self-experiments with delysid (LSD) and psilocybin (CY)
R Gelpke - Journal of psychoactive drugs, 1981 - Taylor & Francis
Sixty seconds on... psilocybin
N Hawkes - 2016 - bmj.com
Timothy Leary: The Harvard years: Early writings on LSD and psilocybin with Richard Alpert, Huston Smith, Ralph Metzner, and others
J Penner - 2014 - books.google.com
Vorkommen von Psilocybin und Baeocystin in Fruchtkörpern von Pluteus salicinus
J Gartz - Planta Medica, 1987 - thieme-connect.com
… Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging
CB Germann - Medical hypotheses, 2020 - Elsevier
Neurobiology of the effects of psilocybin in relation to its potential therapeutic targets
F Tyls, T Palenicek, J Horacek - … of drug addictions and substance misuse, 2016 - Elsevier
Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review
JP Reinert, K Colunga, A Etuk… - Expert Review of …, 2020 - Taylor & Francis
Elucidation of the structure and the synthesis of psilocybin
P ZILKA - Experientia, 1958 - europepmc.org
Psilocin, psilocybin, serotonin and urea in
T Stijve - Panaeolus cyanescens, 1992 - repository.naturalis.nl
Psilocybin Therapeutic Research: The Present and Future Paradigm
RB Kargbo - ACS Medicinal Chemistry Letters, 2020 - ACS Publications
Simultaneous determination of γ-hydroxybutyric acid, ibotenic acid and psilocybin in saliva samples by capillary electrophoresis coupled with a contactless …
P Saar-Reismaa, M Vaher, M Kaljurand, M Kulp… - Analytical …, 2017 - pubs.rsc.org
Psilocybin and spiritual experience
K Bunch - 2009 - Citeseer
Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF)
V Ramachandran, C Chunharas, Z Marcus, T Furnish… - Neurocase, 2018 - Taylor & Francis
Clinical, biochemical and psychologic effects of psilocybin.
LE Hollister - Archives internationales de pharmacodynamie et de …, 1961 - ncbi.nlm.nih.gov
Ethics and ego dissolution: the case of psilocybin
WR Smith, D Sisti - Journal of Medical Ethics, 2020 - jme.bmj.com
Understanding the religious import of mystical states of consciousness facilitated by psilocybin
WA Richards, JH Ellens, B Roberts - The Psychedelic Policy …, 2015 - books.google.com
Psilocybin: Promising results in double-blind trials require confirmation by real-world evidence
A Breckenridge, DE Grobbee - Journal of Psychopharmacology, 2016 - ciis.edu
A phenomenological examination of psilocybin and its positive and persisting aftereffects
JA Zamaria - NeuroQuantology, 2016 - pdfs.semanticscholar.org
Magic mushroom explorer: Psilocybin and the awakening earth
SG Powell - 2015 - books.google.com
EEG changes after psilocybin in organic brain lesions.
J Kolarik - Activitas nervosa superior, 1971 - psycnet.apa.org
Psilocybin Therapy for Major Depressive Disorder
JJH Rucker - Advances in Psychedelic Medicine: State-of-the-Art …, 2019 - books.google.com
A new behavior change program using psilocybin.
L Timothy, M Ralph, P Madison, W Gunther… - … : Theory, Research & …, 1965 - psycnet.apa.org
Detection of psilocybin in species of Psilocybe, Panaeolus and Psathyrella.
J OTT - 1976 - pascal-francis.inist.fr
Taxonomic Identification of Hallucinogenic Mushrooms Seized on the Illegal Market Using a DNA-Based Approach and LC/MS-MS Determination of Psilocybin and …
V Gambaro, G Roda, GL Visconti, S Arnoldi, E Casagni… - 2015 - air.unimi.it
Altered trajectories in the dynamical repertoire of functional network states under psilocybin
LD Lord, P Expert, S Atasoy, L Roseman, K Rapuano… - BioRxiv, 2018 - biorxiv.org
… identification of basidiospores in hallucinogenic mushrooms cultivated in “grow-kits” seized by the police: LC-UV quali-quantitative determination of psilocybin and …
V Gambaro, G Roda, GL Visconti, S Arnoldi… - … of Pharmaceutical and …, 2016 - Elsevier
Psilocybin and Relationship Satisfaction
E Edelson - 2017 - search.proquest.com
Consistency of psilocybin induced changes in the Minnesota Multiphasic Personality Inventory.
MH Keeler, EF Doehne - Journal of clinical psychology, 1965 - psycnet.apa.org
Psilocybin for depression: Considerations for clinical trial design
KC O'Donnell, SE Mennenga… - Journal of Psychedelic …, 2019 - akjournals.com
Psilocybin for the treatment of substance use disorders
I Rao, G Lydall - Advances in Psychedelic Medicine: State-of-the …, 2019 - books.google.com
Tolerability, assessment, and prediction of psilocybin-induced altered states of consciousness
E Studerus - 2012 - zora.uzh.ch
Potential therapeutic effects of psilocybin/psilocin are minimized while possible adverse reactions are overrated
RG dos Santos - Therapeutic drug monitoring, 2014 - journals.lww.com
Psilocybin: a pharmacological profile.
HY Aboul-Enein - American journal of pharmacy and the sciences …, 1974 - ncbi.nlm.nih.gov
A potential role for psilocybin in the treatment of obsessive-compulsive disorder
E Jacobs - Journal of Psychedelic Studies, 2020 - akjournals.com
Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Survivors
B Anderson, A Danforth, R Daroff, C Stauffer… - Biological …, 2019 - clinicaltrials.gov
Detection of psilocybin mushroom analogs in chocolate: Incorporating current events into the undergraduate teaching laboratory
B Huskins, C Dockery - The Chemical Educator, 2009 - digitalcommons.kennesaw.edu
Biosynthesis of psilocybin in submerged culture of Psilocybe cubensis. 1. Incorporation of labelled tryptophan and tryptamine.
S Agurell, S Blomkvist, P Catalfomo - Acta pharmaceutica Suecica, 1966 - ncbi.nlm.nih.gov
Occurrence of psilocybin in the sporophores of Psilocybe semilanceata
PG Mantle, ES Waight - Transactions of the British Mycological Society, 1969 - Elsevier
A biosynthetic sequence from tryptophan to psilocybin.
S Agurell, JL Nilsson - Tetrahedron letters, 1968 - ncbi.nlm.nih.gov
Occurrence of Psilocybin and Baeocystin in Fruit Bodies of Pluteus salicinus.
J Gartz - Planta medica, 1987 - europepmc.org
Studies on psilocybin and related compounds. I. Communication. Structure/activity relationship of oxyindole-derivatives with regard to their effect on the …
H Weidmann, A Cerletti - Helvetica physiologica et …, 1960 - ncbi.nlm.nih.gov
The occurrence of the psychotomimetic agent psilocybin in an Australian agaric, Psilocybe subaeruginosa
J Picker, RW Rickards - Australian Journal of Chemistry, 1970 - CSIRO
Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
MK Madsen, PM Fisher, D Burmester… - …, 2019 - ncbi.nlm.nih.gov
Additional evidence supporting the occurrence of psilocybin in Panaeolus foenisecii.
JE Robbers, VE Tyler, GM Ola'h - Lloydia, 1969 - ncbi.nlm.nih.gov
Expressive phenomenology of model psychoses (psilocybin). Comparison with self-description and psychic deficiency of performance
H Heimann - Psychiatria et neurologia, 1961 - ncbi.nlm.nih.gov
Exposure‐Response Analysis to Assess the Concentration‐QTc Relationship of Psilocybin/Psilocin
E Dahmane, PR Hutson… - Clinical Pharmacology in …, 2020 - Wiley Online Library
Psilocybin: panacea or placebo?
C Hendrie, A Pickles - The Lancet Psychiatry, 2016 - thelancet.com
Psilocybin-public available psychodysleptic
K Dydak, M Śliwińska-Mossoń… - Postepy higieny i …, 2015 - pubmed.ncbi.nlm.nih.gov
Serotonin-like and antiserotonin properties of psilocybin and psilocin
DW Woolley, NK Campbell - Science, 1962 - science.sciencemag.org
Similarity of schizophrenia and the psilocybin syndrome as determined by objective methods.
MH Keeler - International journal of neuropsychiatry, 1965 - europepmc.org
Psilocybin-containing mushrooms, Upper Palaeolithic rock art and the neuropsychological model
PA Helvenston - Rock Art Research: The Journal of the …, 2015 - search.informit.com.au
Psilocybin-induced changes in psychologic function, electroencephalogram, and light-evoked potentials in human subjects.
RR Rynearson, MR Wilson Jr… - Mayo Clinic …, 1968 - ncbi.nlm.nih.gov
Psilocybin, a psychotropic substance from the Mexican mushroom Psilicybe mexicana Heim
A Hofmann, R Heim, A Brack, H Kobel - Experientia, 1958 - ncbi.nlm.nih.gov
Psilocybin compositions
PE Stamets - US Patent App. 16/211,281, 2019 - Google Patents
Question-based Drug Development for psilocybin–Authors' reply
RL Carhart-Harris, DJ Nutt - The Lancet Psychiatry, 2016 - thelancet.com
The effect of bufotenine, melatonin, psilocybin, and related compounds on the 5-hydroxytryptamine excitatory receptors of Helix aspersa neurons
RJ Walker, GN Woodruff - Comparative and General Pharmacology, 1972 - Elsevier
The relationship of carbon and nitrogen nutrition of Psilocybe baeocystis to the production of psilocybin and its analogs.
AY Leung, AG Paul - Lloydia, 1969 - ncbi.nlm.nih.gov
Risiken und Nebenwirkungen von LSD, Psilocybin und MDMA in der Psychotherapie
L Hermle - Therapie mit psychoaktiven Substanzen, 2008 - researchgate.net
Effects of psilocybin on functional connectivity measured with fNIRS: Insights from a single-subject pilot study
F Scholkmann, L Holper, KH Preller, FX Vollenweider - Matters, 2019 - sciencematters.io
Kliniske erfaringer med psilocybin
K Kjærbye Kristensen - Nordisk Psykiatrisk Tidsskrift, 1963 - Taylor & Francis
A comparative literature survey of psilocybin and LSD-25 metabolism
I Joyce - 2017 - dspace.calstate.edu
Personality trait dependent performance under psilocybin. II.
K Thatcher, T Kappeler, P Wisecup… - Diseases of the nervous …, 1970 - ncbi.nlm.nih.gov
Psilocybin reactivity and time contraction as measured by psychomotor performance
R Fischer, SM England, RC Archer, RK Dean - Arzneimittel-Forschung, 1966 - safetylit.org
Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons
NE ANDÉN, H CORRODI, K FUXE - Journal of Pharmacology and …, 1971 - ASPET
Psilocybin based therapy for cancer related distress, a systematic review and meta analysis
C Bahi - arXiv preprint arXiv:1910.05176, 2019 - arxiv.org
Psilocybin slows binocular rivalry switching through serotonin modulation.
O Carter, J Pettigrew, F Hasler, G Wallis… - Journal of …, 2006 - academia.edu
Denver votes to decriminalise psilocybin mushrooms
P Webster - The Lancet, 2019 - thelancet.com
Your Psilocybin Mushroom Companion: An Informative, Easy-to-Use Guide to Understanding Magic Mushrooms—From Tips and Trips to Microdosing and …
M Janikian - 2019 - books.google.com
Psychedelic effects of psilocybin correlate with serotonin 2 A receptor occupancy and plasma psilocin levels
S Stenbæk, S Kristiansen, SS Johansen, S Lehel… - 2019 - nature.com
Effects of mescaline and psilocybin on dominance behavior of the rat.
ET Uyeno - Archives internationales de pharmacodynamie et de …, 1967 - europepmc.org
Psilocybin and LSD in the Treatment of Depression and Anxiety
M Allgulin - 2020 - diva-portal.org
How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans.
T Hirschfeld, TT Schmidt - bioRxiv, 2020 - biorxiv.org
Abductin: a rubber-like protein from the internal triangular hinge ligament of Pecten
RE Kelly, RV Rice - Science, 1967 - science.sciencemag.org
Psilocybe semilanceata (Fr.) Quel.(Spitzkegliger Kahlkopf): Nachweis von Psilocybin in deutschen Funden
H Michaelis - Zeitschrift fur Pilzkunde, 1977 - agris.fao.org
An Adaptive Cognitive Temporal-Causal Model for Extreme Emotion Extinction Using Psilocybin
SSM Ziabari, J Treur - Proceedings of the Computational Methods in …, 2019 - Springer
Unifying electron transfer mechanism for psilocybin and psilocin.
P Kovacic - Medical hypotheses, 2009 - ncbi.nlm.nih.gov
Compositions and methods comprising a psilocybin derivative
AR Chadeayne - US Patent App. 15/893,562, 2018 - Google Patents
Obtaining psilocybin and psilocin from fungal material
H Roger, H Albert, B Artur, K Hans, C Roger - US Patent 3,183,172, 1965 - Google Patents
Compositions comprising a psilocybin derivative and a cannabinoid
AR Chadeayne - US Patent App. 16/192,736, 2019 - Google Patents
THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to Depression
I Stendahl - 2019 - diva-portal.org
The effects of Psilocybin, dextro‐amphetamine and placebo on performance of the trail making test
RB Duke, MH Keeler - Journal of clinical psychology, 1968 - Wiley Online Library
Synthesis of baeocystin, a natural psilocybin analogue
R Brenneisen, S Borner, N Peter‐Oesch… - Archiv der …, 1988 - Wiley Online Library
Decomposing the Shadow: Lessons from the Psilocybin Mushroom
JW Jesso - 2013 - books.google.com
INTEGRATING PSILOCYBIN AND EXISTENTIAL-HUMANISTIC PSYCHOTHERAPY FOR PATHOLOGICAL GAMBLING TREATMENT: A NEW PERSPECTIVE.
T Simona Re, G Penazzi, NL Bragazzi… - Cosmos & …, 2019 - search.ebscohost.com
Magic truffles or Philosopher's stones: a legal way to sell psilocybin?
M Pellegrini, MC Rotolo, E Marchei… - Drug testing and …, 2013 - Wiley Online Library
On similar linguistic structures in creative performance and psilocybin-induced experience.
M Landon, R Fischer - … der Psychiatrie. Les Confins de la …, 1970 - europepmc.org
Fungi containing psilocybin hallucinogens. Wild Danish mushrooms containing intoxicants.
JF Lassen, HB Ravn, SF Lassen - Ugeskrift for Læger, 1990 - cabdirect.org
Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice
J Grandjean, D Buehlmann, M Buerge, H Sigrist… - bioRxiv, 2019 - biorxiv.org
Method of inducing therapeutic tranquilization with psilocybin and psilocin
H Albert, B Arthur, K Hans, H Roger, C Roger - US Patent 3,192,111, 1965 - Google Patents
Different reaction of focal and diffuse epileptic EEG activity to psilocybin.
J Kolarík - Activitas nervosa superior, 1971 - psycnet.apa.org
Towards a molecular approach for the identification of fungal taxa that contain psilocybin
JCI Lee - 2001 - ethos.bl.uk
Mushroom Medicine: The Healing Power of Psilocybin & Sacred Entheogen History
BA Jackson - 2015 - books.google.com
A social and cultural history of the federal prohibition of psilocybin
CD Wark - 2007 - mospace.umsystem.edu
Profiles of psychedelic drugs. Psilocybin.
AT Shulgin - Journal of psychedelic drugs, 1980 - europepmc.org
Long-Term Analysis of Psilocybin in Cancer Patients With Distress
R Simoneaux - 2020 - journals.lww.com
5-MeO-DIPT, a psychedelic structurally related to psiloc (yb) in
E Freye - Pharmacology and Abuse of Cocaine, Amphetamines …, 2009 - Springer
The effects of psilocybin on EEG and behaviour in monkeys.
M Horibe - Activitas nervosa superior, 1974 - ncbi.nlm.nih.gov
Chronic cluster headache: response to psilocybin
AP Sempere, L Berenguer-Ruiz, F Almazan - Revista de neurologia, 2006 - europepmc.org
A/B Extraction and Isolation of Psilocybin
GU Fungi, JF Casale - Future, 2020 - future4200.com
LA PSILOCYBIN~ E
H MICHAUX - 1960 - jontrot.free.fr
The Therapeutic Potential of Psilocybin and 3, 4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder
S Gyllvik - 2020 - diva-portal.org
HPLC analysis of hallucinogenic mushroom alkaloids (Psilocin and Psilocybin) applying Hydrophilic Interaction Chromatography (HILIC)
J Nagy, T Veress - Journal of Forensic Research, 2016 - researchgate.net
Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 69–84
H Heimann - European Neurology, 1961 - karger.com
Possible uses of psilocybin and muscarin alkaloids in the chemotaxonomy of Inocybe (Fr.) Fr.
LS Gurevich, EL Nezdoĭminogo - Mikologiya i Fitopatologiya, 1990 - cabdirect.org
The Screening of Mushrooms Found in Trinidad to Determine the Presence of the Psychoactive Substances Psilocin and Psilocybin
L Garraway, R Maharaj - Living World, Journal of the Trinidad and Tobago …, 2007 - ttfnc.org
Determination of psilocybin and psilocin in hallucinogenic mushrooms by HPLC with diode array and MS detection
RC Van Orden - 2008 - thevespiary.org
The effects of d-amphetamine, 2, 5-dimethoxy-4-methyl-amphetamine (DOM), and psilocybin on fixed-interval responding in the rat.
HA Tilson, WJ Marquis, RH Rech - … of the Annual Convention of the …, 1973 - psycnet.apa.org
Halluzinogene: LSD, Psilocybin und Mescalin
H Konzett - Dtsch Ärztebl, 1981 - cdn.aerzteblatt.de
The Utility of Psilocybin in Managing Anxiety and Depression in Cancer Patients
CH Lim, B Kangas, J Bergman - Journal of Young Investigators, 2018 - jyi.org
Physostigmine reversal of psilocybin intoxication
JF Van Poorten, R Stienstra… - … : The Journal of …, 1982 - anesthesiology.pubs.asahq.org
An adaptive cognitive temporal-causal model for extreme emotion extinction using psilocybin
SS Mohammadi Ziabari, J Treur - 2019 - narcis.nl
Conceptions and Attitudes towards Psilocybin Mushrooms
AA Roy, L Plackova, S Ippolito, Z Turgeon, H Juel… - 2020 - rucforsk.ruc.dk
Psilocybin administration to healthy participants: safety and feasibility in a placebo-controlled study
J Rucker, A Young, C Bird, A Daniel… - …, 2019 - compasspathways-posters.com
The effects of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rats.
O Ladefoged - Archives internationales de pharmacodynamie et de …, 1973 - europepmc.org
Role of Prefrontal Serotonin-2A Receptors in Self-experience During Psilocybin Induced Altered States
F Hasler, BB Quednow, V Treyer… - …, 2009 - research-collection.ethz.ch
On the treatment of therapy-resistant neuroses with model psychoses (psilocybin)
H Heimann - Schweizer Archiv fur Neurologie, Neurochirurgie und …, 1962 - europepmc.org
Question-based Drug Development for psilocybin
FM Dijkstra, GE Jacobs, AF Cohen - The Lancet Psychiatry, 2016 - thelancet.com
the Potential of Psilocybin administration in terminal Cancer Patients
R Simoneaux - 2019 - journals.lww.com
Mapping Psilocybin-Assisted Therapies: A Scoping Review
RJ Shore, P Ioudovski, S McKeown, E Dumont… - medRxiv, 2019 - medrxiv.org
The effect of psilocybin upon the systemic, pulmonary, and coronary circulation of the intact dog.
GM Maxwell, GM Kneebone… - Archives internationales de …, 1962 - ncbi.nlm.nih.gov
Clinical experiences with psilocybin (CY 39 Sandoz)
M Sercl, J Kovarik, O Jaros - Psychiatria et neurologia, 1961 - ncbi.nlm.nih.gov
A Review of the Effects of Psilocybin on Depression and Personality
J Salas - 2020 - vtext.valdosta.edu
… and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or …
PE Stamets - US Patent App. 15/494,503, 2018 - Google Patents
Integrating Psilocybin and Existential-Humanistic Psychotherapy for Pathological Gambling Treatment: A New Perspective
T Re, G Penazzi, NL Bragazzi… - Cosmos and History …, 2019 - cosmosandhistory.org
erste Nachweis des Vorkommens von Psilocybin in Rsspilzen
J Gartz, G Drewitz - Zeitschrift fur Mykologie, 1985 - agris.fao.org
Nachweis und quantitative Bestimmung von Psilocin-und Psilocybin in halluzinogenen Pilzen
M Schläpfer, M Bovens - Toxichem+ Krimtech, 2003 - gtfch.org
The effect of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rabbits.
O Ladefoged - Archives internationales de pharmacodynamie et de …, 1974 - europepmc.org
Effect of psilocybin on the behavior of normal mice & waltzing mice; comparison with lysergic acid monoethylamide & diethylamide
J Delay, J Thuillier, H Nakajima… - Comptes rendus des …, 1959 - europepmc.org
… of the carpophores and sclerotia in culture of Psilocybe mexicana Heim, a Mexican, hallucinogenic agaric, and the demonstration of the presence of psilocybin and …
R Heim, A Brack, H Kobel, A Hofmann… - Revue de …, 1958 - cabdirect.org
Psychedelic revival: a mixed-methods analysis of recreational magic mushroom (psilocybin) use for transformational, micro-dosing and leisure purposes
LV Shaw - 2018 - dspace.library.uvic.ca
Motivationen und Morphologie des Freizeitgebrauchs von Psychedelika (LSD, Psilocybin-Pilze): eine qualitative Interviewstudie
S Prepeliczay - 2016 - media.suub.uni-bremen.de
Quantitative measurement of time contraction induced by psilocybin.
O Tosi, MA Rockey, R Fischer - Arzneimittel-Forschung, 1968 - europepmc.org
The Efficacy of Psilocybin Compared to Selective Serotonin Reuptake Inhibitors in the Treatment of Adults with Major Depressive Disorder
K Worden - 2020 - scholarworks.arcadia.edu
Use of MDMA & Psilocybin in the Treatment of PTSD
C Grant-Howard, J Steele - 2019 - pdxscholar.library.pdx.edu
Ego Death Resulting from Psilocybin Experiences: Exploring the Concept Within Mysticism
M Bobbett - 2017 - search.proquest.com
World Report Denver votes to decriminalise psilocybin mushrooms
P Webster - 2019 - dl.uswr.ac.ir
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
Trial of psilocybin versus escitalopram for depression
R Carhart-Harris, B Giribaldi, R Watts… - … England Journal of …, 2021 - Mass Medical Soc
The therapeutic potential of psilocybin
H Lowe, N Toyang, B Steele, H Valentine, J Grant, A Ali… - Molecules, 2021 - mdpi.com
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
N Hesselgrave, TA Troppoli, AB Wulff… - Proceedings of the …, 2021 - National Acad Sciences
Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial
AK Davis, FS Barrett, DG May, MP Cosimano… - JAMA …, 2021 - jamanetwork.com
Investigation of the structure–Activity relationships of psilocybin analogues
AK Klein, M Chatha, LJ Laskowski… - ACS pharmacology & …, 2020 - ACS Publications
Spontaneous and deliberate creative cognition during and after psilocybin exposure
NL Mason, KPC Kuypers, JT Reckweg, F Müller… - Translational …, 2021 - nature.com
Increased global integration in the brain after psilocybin therapy for depression
RE Daws, C Timmermann, B Giribaldi, JD Sexton… - Nature medicine, 2022 - nature.com
Rediscovering psilocybin as an antidepressive treatment strategy
R Zeiss, M Gahr, H Graf - Pharmaceuticals, 2021 - mdpi.com